TRILOGIC PHARMA LLC
Advanced hydrogel platform with in-situ gelation, bioresorption, and adhesion properties
- Sector
- Biotech
- Headquarters
- MONTGOMERY, AL
- Founded
- 2006
- Latest Form D
- $223K, Aug 2012
- Total capital
- $2.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2.7M
- 4 Form D · last Aug 2012
- 171 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 7 pending · first 2019
- Rank in peer group#11 of 54
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$223K
- Private capital raisedForm D · SEC · 3rd filing$415K
- Private capital raisedForm D · SEC · 2nd filing$425K
- Private capital raisedForm D · SEC · 1st filing$1.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 54 peers
Line = medianBiotech · Material
- Granted patents#11 · top 20%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Hemant H AlurResearcherExecutive OfficerLinked by 5 patents
- Alexander H. C. HarwickDirectorNamed in SEC Form D filings
- DANIEL P. WILBANKSDirectorNamed in SEC Form D filings
- Daniel P. WillbanksDirectorNamed in SEC Form D filings
- ERNEST C. HORNSBYDirectorNamed in SEC Form D filings
- HERMANT H. ALURExecutive Officer, DirectorNamed in SEC Form D filings
Show all 13 people
- James A. H. HarwickExecutive Officer, DirectorNamed in SEC Form D filings
- Mark S. PaxtonDirectorNamed in SEC Form D filings
- Marvin M HulletExecutive OfficerNamed in SEC Form D filings
- Randy B. StanleyDirectorNamed in SEC Form D filings
- WESLEY R. HEATONExecutive Officer, DirectorNamed in SEC Form D filings
- William Van HooserDirectorNamed in SEC Form D filings
- WILLIAM C. MAICHLEDirectorNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 12- PendingTopical Formulations And TreatmentsUSPTOApplication 19189876
- GrantedTopical Formulations And TreatmentsUSPTOUS 12,303,563
- GrantedTopical Formulations And TreatmentsUSPTOUS 12,064,404
Show all 12 patent records
- Topical Formulations And TreatmentsAug 7, 2025 · Application 19189876Pending
- Topical Formulations And TreatmentsMay 20, 2025 · US 12,303,563Granted
- Topical Formulations And TreatmentsAug 20, 2024 · US 12,064,404Granted
- Topical Formulations And TreatmentsOct 4, 2022 · US 11,458,113Granted
- Topical Formulations And TreatmentsSep 28, 2021 · US 11,129,896Granted
- Topical Formulations And TreatmentsAug 20, 2019 · US 10,383,833Granted
- Topical Formulations And TreatmentsApplication PCTUS2017055749Pending
- Topical Formulations And TreatmentsApplication 62407598Pending
- Topical Formulations And TreatmentsApplication PCTUS2016042843Pending
- Topical Formulations And TreatmentsApplication 62194518Pending
- Bioadhesive Compositions For Epithelial Drug DeliveryApplication PCTUS2011038906Pending
- Self Solidifying Bioerodible Barrier ImplantApplication PCTUS2008085259Pending
Related companies, and why
- AV Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Diffuse IncSimilar federal contract value in Biotech · null in contracts
- RIPARIAN PHARMACEUTICALS INCSimilar federal contract value in Biotech · null in contracts
- ZymeworksSimilar federal contract value in Biotech · null in contracts
- Transition Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Spinnaker Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .